38
Participants
Start Date
April 1, 2025
Primary Completion Date
July 1, 2026
Study Completion Date
October 1, 2026
SGB-9768
SGB-9768 for subcutaneous (SC) injection
Peking University First Hospital, Beijing
Peking University People's Hospital, Beijing
The Third Xiangya Hospital of Central South University, Changsha
Sichuan Provincial People's Hospital, Chengdu
Guizhou Provincial People's Hospital, Guiyang
The affiliated hospital of Guizhou medical university, Guiyang
The first affiliated hospital, Zhejiang university school of medicine, Hangzhou
Huashan hospital, Shanghai
Northern Jiangsu People's Hospital, Yangzhou
General hospital of ningxia medical university, Yinchuan
Henan Provincial People's Hospital, Zhengzhou
Suzhou Sanegene Bio Inc.
INDUSTRY